生脉注射液治疗冠心病的疗效观察

采用生脉注射液治疗冠心病20例，疗效显著。     

急性白血病的护理体会

急性白血病是造血组织的恶性增生性疾病，以青少年为多见。如不经过治疗，三个月即可死亡。我科自2002年1月至2006年1月共收治急性白血病患者57例。现将护理体会总结如下：     

双酚胺酸对小鼠和大鼠氯化镍解毒及分布的影响

AIM: To study the effect of catecholamic acid (CBMIDA) on detoxication of NiCl2. METHODS: Mice and rats were injected s.c. or i.m. CBMIDA immediately after i.p. NiCl2. Each mouse was injected i.p. CBMIDA after i.v. 63NiCl2 185 kBq, and radioactivities of various tissues were measured with liquid scintillation counter at 24 h. The localization of 63Ni was shown by the whole-body autoradiography. RESULTS: CBMIDA s.c. 0.5-1.5 g.kg-1 markedly reduced the mortality from acute poisoning of i.p. NiCl2 500 mg.kg-1. After i.p. NiCl2 in mice, the LD50 was 82.7 mg.kg-1. Mice were injected s.c. CBMIDA 1.5 or 2.5 g.kg-1 after Ni poisoning, the LD50 of NiCl2 were raised to 789 or 820 mg.kg-1, respectively. The LD50 of NiCl2 was 39 mg.kg-1 in rat. If CBMIDA was injected i.m. 0.5 g.kg-1 after i.p. NiCl2, the LD50 was 332 mg.kg-1. CBMIDA 1.5 g.kg-1 i.m. after i.v. 63NiCl2, decreased the contents of 63Ni in blood and lung of mice vs control mice at 24 h. The contents of 63Ni in brain, heart, spleen, and kidney were similar to those of the control mice. The content of 63Ni in bone was more than the control. The excretions of 63Ni through urine and feces were not increased by CBMIDA at 24 h. The whole-body autoradiography showed that the radioactivity was highly localized in the kidney, lung, and Harder's gland. There was a moderate level of 63Ni in the liver, bone, skin, and blood. A pronounced accumulation occurred in the bone. There was a marked reduction of 63Ni in the lung, skin, liver, and blood after i.p. CBMIDA. CONCLUSION: The CBMIDA markedly raised the survival rate of nickel-poisoned mice and rats, and decreased 63Ni levels in lung and blood.     

骶管药物注射疗法穿刺术技巧问题探讨

骶疗穿刺术即利用骶管的解剖特征，将自制复合液体经骶管滴注（或注射）作用于脊椎的病变部位，从而达到治疗腰腿痛目的。现被国内外广泛的应用于临床，并获得了满意疗效。但如今由于医护人员骶疗穿刺术（简称穿刺术）不熟练，给治疗带来一定的影响，且增加了病人的痛苦。...     

一个家族的wilson氏病临床综合报告

本文通过一家族八人中,五人不同程度患病情况的报告,复习了有关资料.认为:1.肝病虽为本病的前驱症状,但也可为主要症状及致死原因;2.本病呈家族性,当发现先证病例后,进行家系普查以发现早期潜在型病例;3.早期诊断及治疗,预防感染等有利于降低死亡率;4.皮肤改变是否与本病有关尚有待于进一步探讨.1 家系图及发病情况     

息隐伍米索前列醇两种给药方法流产效果观察

515例早孕妇女采用息隐伍米索前列醇终止妊娠。观察组289人，米索前列醇后穹窿给药，对照组266人．米索前列醇口服给药。结果：两组首次用米索前列醇完全流产率分别为98．96％、88．94％，差异显著（P＜0．01）。观察组首次用米索前列醇流产时间为3．12±0．93h，而对照组为2．59±1．15h，（P＜0．01），有显著差异。副反应率观察组为22．49％，对照组为53．54％，有显著差异（P＜0．01）。因此，息隐伍米索前列醇后穹窿放药安全有效，副反应少。